FI114141B - Stabiilit kuivapulverit - Google Patents

Stabiilit kuivapulverit Download PDF

Info

Publication number
FI114141B
FI114141B FI950282A FI950282A FI114141B FI 114141 B FI114141 B FI 114141B FI 950282 A FI950282 A FI 950282A FI 950282 A FI950282 A FI 950282A FI 114141 B FI114141 B FI 114141B
Authority
FI
Finland
Prior art keywords
glu
gly
asn
hirudin
cys
Prior art date
Application number
FI950282A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI950282A (fi
FI950282A0 (fi
Inventor
Tudor Arvinte
Original Assignee
Ucp Gen Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucp Gen Pharma Ag filed Critical Ucp Gen Pharma Ag
Publication of FI950282A0 publication Critical patent/FI950282A0/fi
Publication of FI950282A publication Critical patent/FI950282A/fi
Application granted granted Critical
Publication of FI114141B publication Critical patent/FI114141B/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • A61K38/57Protease inhibitors from animals; from humans
    • A61K38/58Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Glanulating (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Detergent Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Saccharide Compounds (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI950282A 1994-01-26 1995-01-23 Stabiilit kuivapulverit FI114141B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9401448 1994-01-26
GB9401448A GB9401448D0 (en) 1994-01-26 1994-01-26 Stable dry powders

Publications (3)

Publication Number Publication Date
FI950282A0 FI950282A0 (fi) 1995-01-23
FI950282A FI950282A (fi) 1995-07-27
FI114141B true FI114141B (fi) 2004-08-31

Family

ID=10749332

Family Applications (1)

Application Number Title Priority Date Filing Date
FI950282A FI114141B (fi) 1994-01-26 1995-01-23 Stabiilit kuivapulverit

Country Status (20)

Country Link
US (1) US5733874A (ja)
EP (1) EP0665019B1 (ja)
JP (1) JP3350604B2 (ja)
KR (1) KR100360784B1 (ja)
AT (1) ATE195426T1 (ja)
AU (1) AU701886B2 (ja)
CA (1) CA2140971C (ja)
CY (1) CY2259B1 (ja)
DE (1) DE69518342T2 (ja)
DK (1) DK0665019T3 (ja)
ES (1) ES2151022T3 (ja)
FI (1) FI114141B (ja)
GB (1) GB9401448D0 (ja)
GR (1) GR3034816T3 (ja)
HU (1) HU216628B (ja)
IL (1) IL112389A (ja)
NO (1) NO316883B1 (ja)
NZ (1) NZ270384A (ja)
PT (1) PT665019E (ja)
ZA (1) ZA95576B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9401447D0 (en) 1994-01-26 1994-03-23 Ciba Geigy Ag Pharmaceutical compositions
DE19607239A1 (de) 1996-02-27 1997-08-28 Behringwerke Ag Pharmazeutische Zusammensetzung, enthaltend Hirudin und Verfahren zu deren Herstellung
KR20000070338A (ko) 1997-01-20 2000-11-25 나가시마 카쭈시게, 노미야마 아키히코 펩티드의 안정화 방법 및 당해 방법을 이용한 펩티드 함유 동결건조 의약조성물
US7795205B2 (en) * 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor
EP1909831A4 (en) 2005-06-14 2013-02-20 Amgen Inc PREPARATIONS OF SPONTANEOUS TAMPING PROTEINS
JP6884858B2 (ja) 2016-10-21 2021-06-09 アムジエン・インコーポレーテツド 医薬製剤及びその製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1243358B (it) * 1990-07-23 1994-06-10 Iketon Farmaceutici Srl Composizioni farmaceutiche per la somministrazione orale di irudina
JP2965359B2 (ja) * 1991-01-07 1999-10-18 積水化学工業株式会社 血液検査用容器
AU659432B2 (en) * 1991-03-08 1995-05-18 Novartis Ag A method for the inhibition or prevention of tumor cell metastasis with hirudin
GB9303275D0 (en) * 1993-02-18 1993-04-07 Ciba Geigy Ag Pharmaceutical compositions

Also Published As

Publication number Publication date
FI950282A (fi) 1995-07-27
HU216628B (hu) 1999-07-28
GR3034816T3 (en) 2001-02-28
DE69518342T2 (de) 2001-02-01
KR100360784B1 (ko) 2003-02-25
NO950274D0 (no) 1995-01-25
AU1131895A (en) 1995-08-03
NO950274L (no) 1995-07-27
ZA95576B (en) 1995-07-26
HU9500216D0 (en) 1995-03-28
US5733874A (en) 1998-03-31
JP3350604B2 (ja) 2002-11-25
DE69518342D1 (de) 2000-09-21
DK0665019T3 (da) 2000-10-30
IL112389A0 (en) 1995-03-30
ATE195426T1 (de) 2000-09-15
NZ270384A (en) 1996-02-27
ES2151022T3 (es) 2000-12-16
CA2140971A1 (en) 1995-07-27
PT665019E (pt) 2001-01-31
JPH07267877A (ja) 1995-10-17
CA2140971C (en) 2008-11-25
HUT70474A (en) 1995-10-30
EP0665019A1 (en) 1995-08-02
AU701886B2 (en) 1999-02-11
NO316883B1 (no) 2004-06-28
CY2259B1 (en) 2003-07-04
KR950031105A (ko) 1995-12-18
IL112389A (en) 2003-05-29
EP0665019B1 (en) 2000-08-16
GB9401448D0 (en) 1994-03-23
FI950282A0 (fi) 1995-01-23

Similar Documents

Publication Publication Date Title
US6025467A (en) Parathyroid hormone derivatives and their use
KR20010032881A (ko) 안정한 테리파라타이드 용액
US5965536A (en) Methods of inhibiting CXC intercrine molecules
FI114141B (fi) Stabiilit kuivapulverit
HU205773B (en) Process for producing new human insulin derivativ and pharmaceutical compositions comprising same as active ingredient
CZ20004525A3 (cs) Analogy inzulínu, způsob jejich přípravy a farmaceutické přípravky obsahující tyto analogy
US20240299552A1 (en) Pharmaceutical Composition of GLP-1/GLP-2 Dual Agonists
Orlowski et al. Biologically potent analogues of salmon calcitonin which do not contain an N‐terminal disulfide‐bridged ring structure
EP0758905B1 (en) Pharmaceutical compositions comprising hirudin
MXPA96003010A (en) Pharmaceutical compositions
US5472938A (en) Pharmaceutical depot compositions containing hirudin
US20240024425A1 (en) Pharmaceutical composition of glp-1/glp-2 dual agonists
US7094880B2 (en) Decorin proteoglycan inhibitor of fibrinogen blood clotting
AU685079B2 (en) Peptide inhibitors of CXC intercrine molecules
CA2026776A1 (en) Stabilized, potent grf analogs
CA2092906A1 (en) Stabilized, potent grf analogs
CA2178927A1 (en) Peptide inhibitors of cxc intercrine molecules

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG

MA Patent expired